CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice

FEMS Immunology and Medical Microbiology

Volumn 32, Issue 1, 2001, Pages 65-71

  Weeratna, Risini D ^a   Brazolot Millan, Cynthia L ^b   McCluskie, Michael J ^a   Davis, Heather L ^a  

^a 725 Parkdale Avenue ^*  (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Alum; CpG dinucleotide; Immunization; Th bias; Vaccine adjuvant

Indexed keywords

ALUMINUM POTASSIUM SULFATE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 4; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE RELEASE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; LYMPHOCYTOTOXICITY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; AGING; ALUM COMPOUNDS; ANIMALS; CPG ISLANDS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; IMMUNIZATION; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDES; TH1 CELLS; TH2 CELLS;

EID: 0035662814     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(01)00267-X     Document Type: Article

References (48)

1. Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches
2. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets
3. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens
4. Schistosomiasis. Parasitizing the cytokine system
5. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis
6. Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine
7. CpG DNA as mucosal adjuvant
8. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major
9. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms
10. Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins
11. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice
12. CpG DNA: A novel adjuvant for systemic and mucosal immunization with influenza virus
13. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
14. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
15. Bacterial DNA induces NK cells to produce interferon-γ in vivo and increases the toxicity of lipopolysaccharide
16. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α
17. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma
18. CpG DNA induces stronger immune responses with less toxicity than other adjuvants
19. Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates
20. Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides
21. H2 immunity in neonatal mice
22. Induction of protective CTL responses in newborn mice by a murine retrovirus
23. Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized
24. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life
25. Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines
26. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming
27. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice
28. Will adjuvants be needed for vaccines of the future?
29. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms
30. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys
31. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies
32. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
33. CpG ODN is safe and highly effective in humans as adjuvant to HBV vaccine: Preliminary results of Phase I trial with CpG ODN 7909
34. CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma
35. Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis
36. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: Predominance of a Th2-biased pattern which persists after adult boosting
37. Immunization with DNA vaccines in early life: Advantages and limitations as compared to conventional vaccines
38. CpG oligodeoxynucleotides can circumvent the TH2 polarization of neonatal responses to vaccines but fail to fully redirect TH2 responses established by neonatal priming
39. Asthma: An epidemic in the absence of infection?
40. Effects of CpG DNA on Th1/Th2 balance in asthma
41. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
42. Partial correction of the TH2/TH1 imbalance in neonatal responses to vaccine antigens through selective adjuvant effects
43. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins
44. Immunostimulatory dna-based vaccines elicit multifaceted immune responses against hiv at systemic and mucosal sites
45. The antigen dose determines T helper subset development by regulation of CD40 ligand
46. Crossregulation between Th1 and Th2 cells
47. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development
48. Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism